2025-11-12T13:54:36-05:00 2024-12-31 522436535 COMER & COMPANY CPA'S LLC 61 MAIN STREET MIDDLETOWN CT 064573408 990EZ 2024-01-01 461995761 INTERNATIONAL LYMPHOMA RADIATION ONCOLOGY FOUNDATION INTE 2126395999 965 EDWARDS LANE ORIENT NY 119571031 JOACHIM YAHALOM MD CHAIRMAN 2126395999 2025-10-31 true false THOMAS D COMER CPA P00129178 8603462100 2025-10-31 2024 2025-03-06 01:10:19Z X WWW.ILROG.COM X X 84748 X 40000 44595 153 84748 48554 420 603 23163 72740 12008 154970 166978 154970 166978 154970 166978 154970 166978 X THE MISSION OF ILROG IS TO IMPROVE THE OUTCOME FOR PATIENTS BY ENCOURAGING THE APPROPRIATE INTEGRATION OF RADIATION THERAPY IN THE MANAGEMENT OF LYMPHOMA. ILROG OBJECTIVES: - TO OPTIMIZE, ADVANCE AND HARMONIZE THE INTEGRATION OF RADIATION THERAPY IN THE MANAGEMENT OF LYMPHOMA PATIENTS. - TO INFORM THE HEMATOLOGY, MEDICAL AND RADIATION ONCOLOGY COMMUNITIES OF THE LYMPHOMA SCENARIOS WHERE APPROPRIATE UTILIZATION OF RADIOTHERAPY IS ADVANTAGEOUS. - TO DEVELOP AND DISSEMINATE EVIDENCE-BASED GUIDELINES FOR RADIOTHERAPY FIELDS, DOSES AND TECHNIQUES FOR ALL TYPES OF LYMPHOMAS. - TO TRAIN RADIATION ONCOLOGISTS WORLDWIDE IN USING MODERN LYMPHOMA RADIOTHERAPY PRINCIPLES AND TECHNIQUES VIA COLLABORATION WITH APPROPRIATE NATIONAL OR REGIONAL SCIENTIFIC SOCIETIES. - TO PROVIDE A WORLDWIDE FORUM FOR RADIATION ONCOLOGISTS WHO TREAT LYMPHOMAS TO DISCUSS AND SHARE INFORMATION AND IDEAS. - TO PROVIDE A SOURCE OF INFORMATION FOR LYMPHOMA PATIENTS EXPLAINING THE ADVANTAGES AND RISKS ASSOCIATED WITH RADIATI 2024 ACCOMPLISHMENTS INCLUDE CONTINUED EDUCATION OF MEMBERSHIP BY CREATING, PUBLISHING AND CREATING GUIDELINES. MULTICENTER COLLABORATION ON RESEARCH PROJECTS. AN INTERNATIONAL CONFERENCE WAS HELD IN BEIJING, CHINA. 68780 68780 JOACHIM YAHALOM MD CHAIRMAN 12.00 0 LENA SPECHT MD VICE-CHAIRMA 8.00 0 TIM ILLIDGE MD SECRETARY/TR 8.00 0 false false false false false false false false false INTERNATIONAL LYMPHOMA RADIATION INTERNATIONAL LYMPHOMA RADIATION 351 E 51ST ST APT 14C 35 E 51ST ST APT 14C NEW YORK NY 10022 2126395999 false false false false false false false false false false false NONE NONE true X 52029 31583 35058 44185 44595 207450 52029 31583 35058 44185 44595 207450 207450 184 127 153 464 184 127 153 464 52213 31583 35058 44312 44748 207914 0.99780 0.99620 0.00000 0.00000 X SUPPORTING SCHEDULE RESEARCH 40,000 RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED FORM 990-EZ, PART I, LINE 16 EXPENSES OFFICE EXPENSES 120 WEBSITE/HOSTING 1,191 TECHNOLOGY EXPENSES 6,084 CONFERENCES & MEETINGS 10,046 BANK FEES 1,990 PAYROLL PROCESSING FEES 913 DUES & SUBSCRIPTIONS 637 AWARDS AND HOST GIFTS 2,182 TOTAL 23,163 FORM 990-EZ, PART III THE MISSION OF ILROG IS TO IMPROVE THE OUTCOME FOR PATIENTS BY ENCOURAGING THE APPROPRIATE INTEGRATION OF RADIATION THERAPY IN THE MANAGEMENT OF LYMPHOMA. ILROG OBJECTIVES: - TO OPTIMIZE, ADVANCE AND HARMONIZE THE INTEGRATION OF RADIATION THERAPY IN THE MANAGEMENT OF LYMPHOMA PATIENTS. - TO INFORM THE HEMATOLOGY, MEDICAL AND RADIATION ONCOLOGY COMMUNITIES OF THE LYMPHOMA SCENARIOS WHERE APPROPRIATE UTILIZATION OF RADIOTHERAPY IS ADVANTAGEOUS. - TO DEVELOP AND DISSEMINATE EVIDENCE-BASED GUIDELINES FOR RADIOTHERAPY FIELDS, DOSES AND TECHNIQUES FOR ALL TYPES OF LYMPHOMAS. - TO TRAIN RADIATION ONCOLOGISTS WORLDWIDE IN USING MODERN LYMPHOMA RADIOTHERAPY PRINCIPLES AND TECHNIQUES VIA COLLABORATION WITH APPROPRIATE NATIONAL OR REGIONAL SCIENTIFIC SOCIETIES. - TO PROVIDE A WORLDWIDE FORUM FOR RADIATION ONCOLOGISTS WHO TREAT LYMPHOMAS TO DISCUSS AND SHARE INFORMATION AND IDEAS. - TO PROVIDE A SOURCE OF INFORMATION FOR LYMPHOMA PATIENTS EXPLAINING THE ADVANTAGES AND RISKS ASSOCIATED WITH RADIATION THERAPY. - TO INITIATE, SUPPORT AND CONDUCT RESEARCH THAT WILL FURTHER THE UNDERSTANDING OF RADIOTHERAPY IN THE TREATMENT OF LYMPHOMA AND THAT WILL IMPROVE THE THERAPEUTIC RATIO OF USING RADIOTHERAPY ALONE OR IN COMBINATION WITH OTHER THERAPIES.